Stay updated on Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    No significant changes to the study page were detected; core details such as the title, phase, eligibility criteria, and locations remain unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:04:44.000Z thumbnail image
  3. Check
    29 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    3%
    Check dated 2025-10-06T08:24:13.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T05:09:23.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed, with no substantive content changes otherwise.
    Difference
    0.2%
    Check dated 2025-09-14T23:06:13.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T19:45:24.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key content related to pembrolizumab and various medical topics has been removed.
    Difference
    2%
    Check dated 2025-08-31T12:33:07.000Z thumbnail image

Stay in the know with updates to Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Consolidation Pembrolizumab in Stage III NSCLC Clinical Trial page.